156 related articles for article (PubMed ID: 21085906)
1. Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.
Juraskova B; Andrys C; Holmerova I; Solichova D; Hrnciarikova D; Vankova H; Vasatko T; Krejsek J
J Nutr Health Aging; 2010 Nov; 14(9):758-61. PubMed ID: 21085906
[TBL] [Abstract][Full Text] [Related]
2. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
[TBL] [Abstract][Full Text] [Related]
3. Differential levels of soluble endoglin (CD105) in myeloid malignancies.
Calabrò L; Fonsatti E; Bellomo G; Alonci A; Colizzi F; Sigalotti L; Altomonte M; Musolino C; Maio M
J Cell Physiol; 2003 Feb; 194(2):171-5. PubMed ID: 12494455
[TBL] [Abstract][Full Text] [Related]
4. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis.
Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK
Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
6. A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease.
Fujimoto M; Hasegawa M; Hamaguchi Y; Komura K; Matsushita T; Yanaba K; Kodera M; Takehara K; Sato S
Dermatology; 2006; 213(2):88-92. PubMed ID: 16902284
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma.
Tsirakis G; Pappa CA; Spanoudakis M; Chochlakis D; Alegakis A; Psarakis FE; Stratinaki M; Stathopoulos EN; Alexandrakis MG
Eur J Intern Med; 2012 Jun; 23(4):368-73. PubMed ID: 22560388
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
9. Combined perioperative plasma endoglin and VEGF--a assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2009; 47(2):231-6. PubMed ID: 19995709
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of the transforming growth factor β system in Turner syndrome.
Zhou J; Arepalli S; Cheng CM; Bakalov VK; Bondy CA
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):720-4. PubMed ID: 23073581
[TBL] [Abstract][Full Text] [Related]
11. Soluble endoglin as a second-trimester marker for preeclampsia.
Robinson CJ; Johnson DD
Am J Obstet Gynecol; 2007 Aug; 197(2):174.e1-5. PubMed ID: 17689640
[TBL] [Abstract][Full Text] [Related]
12. [Profile of serum soluble endoglin in pregnant women with severe pre-eclampsia and eclampsia].
Zhu YC; Sun Y; Yang HX; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):91-3. PubMed ID: 19570416
[TBL] [Abstract][Full Text] [Related]
13. Serum sEPCR levels are elevated in patients with Alzheimer's disease.
Zhu Y; Chen Z; Chen X; Hu S
Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):517-21. PubMed ID: 25588409
[TBL] [Abstract][Full Text] [Related]
14. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.
Perucci LO; Gomes KB; Freitas LG; Godoi LC; Alpoim PN; Pinheiro MB; Miranda AS; Teixeira AL; Dusse LM; Sousa LP
PLoS One; 2014; 9(5):e97632. PubMed ID: 24851923
[TBL] [Abstract][Full Text] [Related]
15. Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis?
Dietmann A; Helbok R; Lackner P; Fischer M; Reindl M; Lell B; Issifou S; Kremsner PG; Schmutzhard E
J Infect Dis; 2009 Dec; 200(12):1842-8. PubMed ID: 19919302
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
Blaha M; Cermanova M; Blaha V; Jarolim P; Andrys C; Blazek M; Maly J; Smolej L; Zajic J; Masin V; Zimova R; Rehacek V
Atherosclerosis; 2008 Mar; 197(1):264-70. PubMed ID: 17540382
[TBL] [Abstract][Full Text] [Related]
18. Circulating endoglin concentration is not elevated in chronic kidney disease.
Charytan DM; Helfand AM; MacDonald BA; Cinelli A; Kalluri R; Zeisberg EM
PLoS One; 2011; 6(8):e23718. PubMed ID: 21886815
[TBL] [Abstract][Full Text] [Related]
19. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
[TBL] [Abstract][Full Text] [Related]
20. Combined perioperative plasma endoglin and VEGF-A assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2008; 46(4):487-92. PubMed ID: 19141403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
